VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia. J Natl Cancer Inst. 2008 Feb 06; 100(3):184-98.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Benzenesulfonates
Cell Line, Tumor
Cell Survival
Fluorescent Antibody Technique
fms-Like Tyrosine Kinase 3
Humans
Immunoblotting
Kaplan-Meier Estimate
Leukemia, Myeloid, Acute
Mice
Mice, SCID
Mutation
Neoplastic Cells, Circulating
Niacinamide
Phenylurea Compounds
Polymerase Chain Reaction
Protein Kinase Inhibitors
Pyridines
Transplantation, Heterologous
authors with profiles
MICHAEL ANDREEFF
ZEEV ESTROV
JORGE E CORTES
MARINA KONOPLEVA
WEIGUO ZHANG